WaveMan · Form 4
Cheng Sohanya Roshan insider trades
> Search tickers & screens ⌘K
LIVE

Cheng Sohanya Roshan insider trades

Cheng Sohanya Roshan has filed 19 Form 4s with the SEC that we hold, for Karyopharm Therapeutics Inc. (KPTI) (EVP & Chief Commercial Officer) and CARM (Director). Across all of them we count 0 purchases worth $0 and 12 sales worth $162.0K reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($46.4K). The largest single trade was a sale of 4,604 shares of Karyopharm Therapeutics Inc. worth $43.3K, dated 2026-03-02. The first filing on our record is dated 2021-07-01 and the latest 2026-05-15.

Karyopharm Therapeutics Inc. (KPTI)

EVP & Chief Commercial Officer · 18 filings · 12 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-06-13S, sale reported on Form 41,485$7.7K2022-06-14
2022-06-13S, sale reported on Form 466$3532022-06-14
2023-03-01S, sale reported on Form 411,239$34.1K2023-03-02
2023-06-08S, sale reported on Form 41,839$4.3K2023-06-12
2023-09-01S, sale reported on Form 47,415$9.9K2023-09-05
2024-02-29S, sale reported on Form 421,840$25.6K2024-03-04
2024-03-01S, sale reported on Form 45,109$6.1K2024-03-04
2024-09-04S, sale reported on Form 45,356$3.9K2024-09-05
2025-03-04S, sale reported on Form 43,445$21.7K2025-03-06
2025-09-15S, sale reported on Form 4325$2.1K2025-09-16
2026-03-02S, sale reported on Form 44,604$43.3K2026-03-03
2026-05-14S, sale reported on Form 4324$3.1K2026-05-15

CARM

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1865796) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms